Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-05-18 09:17:15 UTC |
---|
Update Date | 2023-02-21 17:15:59 UTC |
---|
HMDB ID | HMDB0001943 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Pseudoephedrine |
---|
Description | Pseudoephedrine is a member of the class of phenylethanolamines that is (1S)-2-(methylamino)-1-phenylethan-1-ol in which the pro-S hydrogen at position 2 is replaced by a methyl group. It has a role as a sympathomimetic agent, an anti-asthmatic drug, a bronchodilator agent, a vasoconstrictor agent, a central nervous system drug, a nasal decongestant, a xenobiotic and a plant metabolite. It is a secondary alcohol, a secondary amino compound and a member of phenylethanolamines. It is a conjugate base of a pseudoephedrine(1+). Pseudoephedrine is a sympathomimetic drug of the phenethylamine and amphetamine chemical classes. It may be used as a nasal/sinus decongestant, as a stimulant, or as a wakefulness-promoting agent in higher doses. It was first characterized in 1889, by the German chemists Ladenburg and Oelschlägel, who used a sample that had been isolated from Ephedra vulgaris by the Merck pharmaceutical corporation of Darmstadt, Germany. The salts pseudoephedrine hydrochloride and pseudoephedrine sulfate are found in many over-the-counter preparations, either as a single ingredient or (more commonly) in a fixed-dose combination with one or more additional active ingredients such as antihistamines, guaifenesin, dextromethorphan, paracetamol (acetaminophen) or an NSAID (such as aspirin or ibuprofen). At first, pseudoephedrine was known as a natural substance that occurs in shrubs of the Ephedra genus, which grow worldwide. Almost all commercial pseudoephedrine, however, is produced by fermenting dextrose in the presence of benzaldehyde. The primary product, (R)-phenylacetylcarbinol, is aminated to make pseudoephedrine. Pseudoephedrine acts on α- and β2-adrenergic receptors, to cause vasoconstriction and relaxation of smooth muscle in the bronchi, respectively. α-Adrenergic receptors are located on the muscles lining the walls of blood vessels. When these receptors are activated, the muscles contract, causing the blood vessels to constrict (vasoconstriction). The constricted blood vessels now allow less fluid to leave the blood vessels and enter the nose, throat and sinus linings, which results in decreased inflammation of nasal membranes, as well as decreased mucus production. Thus, by constriction of blood vessels, mainly those located in the nasal passages, pseudoephedrine causes a decrease in the symptoms of nasal congestion. Activation of β2-adrenergic receptors produces relaxation of smooth muscle of the bronchi, causing bronchial dilation and in turn decreasing congestion (although not fluid) and difficulty breathing. |
---|
Structure | CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 InChI=1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10+/m0/s1 |
---|
Synonyms | Value | Source |
---|
(+) Threo-2-(methylamino)-1-phenyl-1-propanol | ChEBI | (+)-(1S,2S)-Pseudoephedrine | ChEBI | (+)-Pseudoephedrine | ChEBI | (+)-Psi-ephedrine | ChEBI | (+)-Threo-ephedrine | ChEBI | (1S,2S)-(+)-Pseudoephedrine | ChEBI | (1S,2S)-Pseudoephedrine | ChEBI | 2-(Methylamino)-1-phenyl-1-propanol | ChEBI | D-Isoephedrine | ChEBI | D-Pseudoephedrine | ChEBI | D-Psi-2-methylamino-1-phenyl-1-propanol | ChEBI | D-Psi-ephedrine | ChEBI | Isoephedrine | ChEBI | L(+)-Psi-ephedrine | ChEBI | L-(+)-Pseudoephedrine | ChEBI | Pseudoefedrina | ChEBI | Pseudoephedrine D-form | ChEBI | Pseudoephedrinum | ChEBI | Psi-ephedrin | ChEBI | Psi-ephedrine | ChEBI | trans-Ephedrine | ChEBI | Neodurasina | Kegg | Acunaso | Kegg | 1-Ephedrine | HMDB | Besan | HMDB | D-Pseudoephedrine base | HMDB | Novafed | HMDB | Pseudoephedrine ephedrine | HMDB | Sudafed | HMDB | Ephedrine threo isomer | HMDB | Pseudoephedrine HCL | HMDB | Threo isomer OF ephedrine | HMDB | Pseudoephedrine hydrochloride | HMDB |
|
---|
Chemical Formula | C10H15NO |
---|
Average Molecular Weight | 165.2322 |
---|
Monoisotopic Molecular Weight | 165.115364107 |
---|
IUPAC Name | (1S,2S)-2-(methylamino)-1-phenylpropan-1-ol |
---|
Traditional Name | pseudoephedrine |
---|
CAS Registry Number | 90-82-4 |
---|
SMILES | CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10+/m0/s1 |
---|
InChI Key | KWGRBVOPPLSCSI-WCBMZHEXSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylpropanes. These are organic compounds containing a phenylpropane moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Phenylpropanes |
---|
Direct Parent | Phenylpropanes |
---|
Alternative Parents | |
---|
Substituents | - Phenylpropane
- Aralkylamine
- 1,2-aminoalcohol
- Secondary alcohol
- Secondary aliphatic amine
- Secondary amine
- Alcohol
- Organopnictogen compound
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Amine
- Aromatic alcohol
- Hydrocarbon derivative
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 119 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | 0.89 | KRIL,MB & FUNG,HL (1990) |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Pseudoephedrine,1TMS,isomer #1 | CN[C@@H](C)[C@@H](O[Si](C)(C)C)C1=CC=CC=C1 | 1413.7 | Semi standard non polar | 33892256 | Pseudoephedrine,1TMS,isomer #2 | C[C@@H]([C@@H](O)C1=CC=CC=C1)N(C)[Si](C)(C)C | 1524.2 | Semi standard non polar | 33892256 | Pseudoephedrine,2TMS,isomer #1 | C[C@@H]([C@@H](O[Si](C)(C)C)C1=CC=CC=C1)N(C)[Si](C)(C)C | 1572.6 | Semi standard non polar | 33892256 | Pseudoephedrine,2TMS,isomer #1 | C[C@@H]([C@@H](O[Si](C)(C)C)C1=CC=CC=C1)N(C)[Si](C)(C)C | 1556.8 | Standard non polar | 33892256 | Pseudoephedrine,2TMS,isomer #1 | C[C@@H]([C@@H](O[Si](C)(C)C)C1=CC=CC=C1)N(C)[Si](C)(C)C | 1691.1 | Standard polar | 33892256 | Pseudoephedrine,1TBDMS,isomer #1 | CN[C@@H](C)[C@@H](O[Si](C)(C)C(C)(C)C)C1=CC=CC=C1 | 1643.6 | Semi standard non polar | 33892256 | Pseudoephedrine,1TBDMS,isomer #2 | C[C@@H]([C@@H](O)C1=CC=CC=C1)N(C)[Si](C)(C)C(C)(C)C | 1754.6 | Semi standard non polar | 33892256 | Pseudoephedrine,2TBDMS,isomer #1 | C[C@@H]([C@@H](O[Si](C)(C)C(C)(C)C)C1=CC=CC=C1)N(C)[Si](C)(C)C(C)(C)C | 2047.3 | Semi standard non polar | 33892256 | Pseudoephedrine,2TBDMS,isomer #1 | C[C@@H]([C@@H](O[Si](C)(C)C(C)(C)C)C1=CC=CC=C1)N(C)[Si](C)(C)C(C)(C)C | 1989.4 | Standard non polar | 33892256 | Pseudoephedrine,2TBDMS,isomer #1 | C[C@@H]([C@@H](O[Si](C)(C)C(C)(C)C)C1=CC=CC=C1)N(C)[Si](C)(C)C(C)(C)C | 2002.5 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Pseudoephedrine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-9200000000-0c3fe6959703a851b9cc | 2017-08-28 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pseudoephedrine GC-MS (1 TMS) - 70eV, Positive | splash10-05cr-4900000000-d9ac11e33b32a9e427ad | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pseudoephedrine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-0a4i-9000000000-8f0484f72b48017f1f2e | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Pseudoephedrine Quattro_QQQ 10V, N/A-QTOF (Annotated) | splash10-016s-3900000000-868bf4bba93d8b4be696 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pseudoephedrine Quattro_QQQ 25V, N/A-QTOF (Annotated) | splash10-0159-2900000000-6c55fc67b7576cb42a8a | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pseudoephedrine Quattro_QQQ 40V, N/A-QTOF (Annotated) | splash10-0006-9700000000-459686cbaf7d3b59c202 | 2012-07-25 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pseudoephedrine 10V, Positive-QTOF | splash10-00kb-0900000000-677d622716b4c2545f16 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pseudoephedrine 20V, Positive-QTOF | splash10-00kb-2900000000-416def0e527ddf116a39 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pseudoephedrine 40V, Positive-QTOF | splash10-0aou-9500000000-155625a572f19610e138 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pseudoephedrine 10V, Negative-QTOF | splash10-03di-0900000000-ea7e1b550b5dc0d6d41d | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pseudoephedrine 20V, Negative-QTOF | splash10-03dj-2900000000-f4de25860574bb60daf1 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pseudoephedrine 40V, Negative-QTOF | splash10-0a6r-9600000000-62e375458e5f83795e90 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pseudoephedrine 10V, Negative-QTOF | splash10-0297-3900000000-4496fbcd8548f7ccc58a | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pseudoephedrine 20V, Negative-QTOF | splash10-014i-1900000000-03e637debccd8d202e3c | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pseudoephedrine 40V, Negative-QTOF | splash10-004i-9100000000-7ead088c2f003219a1cf | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pseudoephedrine 10V, Positive-QTOF | splash10-0002-0900000000-0282f3e8fc4bf9296a38 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pseudoephedrine 20V, Positive-QTOF | splash10-014m-3900000000-8ee8987e88c6a5601ef7 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pseudoephedrine 40V, Positive-QTOF | splash10-0006-9300000000-e3932e53d7936649b8db | 2021-09-25 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|